Stock Titan Trading tools for traders and investors.

-

09:30:32 AM

Last BNTX Stock Market News

BNTX - BioNTech SE

01/22/21 12:00 PM

NYSE, Nasdaq : PFE, BNTX

Pfizer and BioNTech Reach Agreement with COVAX for Advance Purchase of Vaccine to Help Combat COVID-19

Pfizer and BioNTech SE today announced an advance purchase agreement with COVAX for up to 40 million doses of the Pfizer-BioNTech COVID-19 Vaccine. The doses will be delivered throughout 2021.This press release features multimedia. View the full release here:

RHEA-AI

neutral

01/22/21 12:00 PM

Nasdaq : BNTX

Pfizer and BioNTech Reach Agreement with COVAX for Advance Purchase of Vaccine to Help Combat COVID-19

Initial agreement provides up to 40 million doses to COVAX in 2021 First deliveries are expected to take place in Q1 2021 subject to the execution of supply agreements under the COVAX Facility structure For the COVAX Advanced Market Commitment 92 countries, Pfizer and BioNTech will provide the

RHEA-AI

neutral

01/20/21 7:50 AM

Nasdaq : BNTX

Pfizer and BioNTech Publish Results of Study Showing COVID-19 Vaccine Elicits Antibodies that Neutralize Pseudovirus Bearing the SARS-CoV-2 U.K. Strain Spike Protein in Cell Culture

New York and Mainz, Germany, January 20, 2021 -- Today, Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) announced results from an in vitro study that provides additional data on the capability of sera from individuals immunized with the Pfizer-BioNTech COVID-19 vaccine BNT162b2 to neutralize

RHEA-AI

negative

01/08/21 5:45 AM

Nasdaq : BNTX

An In Vitro Study Shows Pfizer-BioNTech COVID-19 Vaccine Elicits Antibodies that Neutralize SARS-CoV-2 with a Mutation Associated with Rapid Transmission

New York and Mainz, Germany, January 8, 2021 -- Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced results from an in vitro study conducted by Pfizer and the University of Texas Medical Branch (UTMB) that shows the antibodies from people who have received the Pfizer-BioNTech

RHEA-AI

negative

01/07/21 2:15 PM

Nasdaq : BNTX

BioNTech Publishes Data on Novel mRNA Vaccine Approach to Treat Autoimmune Diseases in Science

Collaborative study of BioNTech with TRON and the University Medical Center and Research Center for Immunotherapy at Johannes Gutenberg University of Mainz introduces novel non-inflammatory mRNA vaccine encoding disease-related autoantigens that suppressed disease activity in several complex mouse

RHEA-AI

neutral

01/05/21 6:00 AM

Nasdaq : BNTX

BioNTech to Present at the 39th Annual J.P. Morgan Healthcare Conference

MAINZ, GERMANY, January 5, 2021 -- BioNTech SE (Nasdaq: BNTX, "BioNTech" or "the Company") announced today that CEO and Co-founder Ugur Sahin, M.D., will present a corporate overview and update at the virtual 39 th Annual J.P. Morgan Healthcare Conference on Monday, January 11,

RHEA-AI

neutral

12/29/20 1:11 PM

NYSE, Nasdaq : PFE, BNTX

Pfizer and BioNTech to Supply the European Union with 100 Million Additional Doses of COMIRNATY(R)

Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced they will supply an additional 100 million doses of COMIRNATY (R), the companies' COVID-19 Vaccine, to the 27 European Union (EU) member states in 2021. This announcement is a result of the European Commission's decision to

RHEA-AI

neutral

12/29/20 1:10 PM

Nasdaq : BNTX

Pfizer and BioNTech to Supply the European Union with 100 Million Additional Doses of COMIRNATY(R)

European Union orders 100 million additional doses of COMIRNATY (R) bringing total doses to 300 million for 27 EU member states All 300 million doses expected to be delivered in 2020 and 2021 NEW YORK and MAINZ, GERMANY, December 29, 2020 -- Pfizer Inc. (NYSE: PFE) and BioNTech SE

RHEA-AI

positive

12/23/20 7:44 AM

Nasdaq : BNTX

Correction: Pfizer and BioNTech to Supply the U.S. with 100 Million Additional Doses of COVID-19 Vaccine

U.S. government orders 100 million additional doses of the Pfizer-BioNTech COVID-19 vaccine bringing total doses for U.S. to 200 million All 200 million doses will be produced by U.S. manufacturing facilities and are expected to be delivered by July 31, 2021, allowing for 100 million people in the

RHEA-AI

neutral

12/23/20 7:02 AM

Nasdaq : BNTX

Pfizer and BioNTech to Supply the U.S. with 100 Million Additional Doses of COVID-19 Vaccine

U.S. government orders 100 million additional doses of the Pfizer-BioNTech COVID-19 vaccine bringing total doses for U.S. to 200 million All 200 million doses will be produced by U.S. manufacturing facilities and are expected tobe delivered by July 31, 2021, allowing for 100 million people in the

RHEA-AI

neutral

Prev 1 2 3 4 5 6 7 8 Next